The 2026 edition of the Japan neurotechnology device market overview examines the characteristics of the domestic market, major companies and applications in the context of a comparison with the global market. Against the backdrop of an aging society, demand is concentrated in the medical and nursing care sectors, with regulatory compliance and the distribution networks of established major companies considered important.
In the global market, use is expanding beyond medical and research institutions to include general consumers, and the market is said to be growing as a result of advances in non-invasive wearables and AI-based signal analysis. The practical application of brain-computer interfaces is viewed as a potential catalyst for market expansion.
Compared with overseas markets, Japan's market is focused on the medical and nursing care sectors, with strong demand for devices intended for dementia rehabilitation and functional recovery after stroke. Obtaining certification compliant with Japan's pharmaceutical and medical device regulations is essential, giving major companies an advantage over emerging overseas startups through their distribution networks and reliability. Adoption is cautious, and clinical evidence tends to be given priority.
Applications attracting attention in Japan include functional recovery after stroke and monitoring of cognitive function. Sleep-monitoring devices are also considered to have the potential to reduce health risks. These applications are directly linked to national challenges such as containing medical costs and extending healthy life expectancy.
Major companies cited include global leaders such as Medtronic, Boston Scientific, Abbott, NeuroPace and Kernel. Competition in the Japanese market is described as centering on cooperation between established large companies and medical device manufacturers.